查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1754324

2025 年至 2033 年氧合器市场规模、份额、趋势及预测（按类型、年龄层、应用和地区）

Oxygenators Market Size, Share, Trends and Forecast by Type, Age Group, Application, and Region, 2025-2033
出版日期: | 出版商: IMARC | 英文 140 Pages | 商品交期: 2-3个工作天内

价格

2024年，全球氧合器市场规模为2.719亿美元。展望未来， IMARC Group估计，到2033年，市场规模将达到4.1952亿美元，2025年至2033年的复合年增长率为4.94%。北美目前占据市场主导地位，2024年的市占率将超过45.3%。该地区心血管和呼吸系统疾病的高发病率、外科手术的增多以及医疗基础设施的强劲发展推动了氧合器市场的发展。

全球氧合器市场受全球心血管和呼吸系统疾病日益普及的驱动。根据世界卫生组织 (WHO) 的数据，30 至 70 岁人群中，心血管疾病 (CVD)、癌症、糖尿病或慢性呼吸系统疾病的死亡风险为 18%。这增加了重症监护和外科手术对氧合器的需求，从而促进了市场成长。此外，医疗技术的不断进步提高了氧合器的效率和安全性，提高了采用率，并刺激了市场需求。此外，老年人口的增加也促进了市场扩张，因为慢性疾病需要氧合支持。此外，外科手术（尤其是开胸心臟手术）数量的增加也推动了市场成长。此外，新兴经济体医疗基础设施的不断扩大提高了人们获得先进医疗设备的机会，从而促进了市场成长。

美国氧合器市场占有83.20%的市占率。该地区的需求成长主要源自于心血管疾病和肺部疾病的高发性。同时，人口老化也对氧合器市场产生了显着的影响，因为老年人更容易患上需要氧合支持的慢性疾病。此外，美国发达的医疗保健体系确保了尖端技术的广泛普及，促进了市场的成长。同时，心臟手术和体外膜氧合 (ECMO) 手术数量的增加也为市场提供了动力。此外，氧合器技术的持续进步提高了效率和安全性，从而促进了其普及并推动了市场的发展。

氧合器市场趋势：

心臟病盛行率不断上升

心臟病病例是全球氧合器需求成长的主要原因。英国心臟基金会于2024年1月发布的研究发现，光是在亚洲，就有约6.4亿人患有心臟和循环系统疾病。随着患者数量的稳定增长，患者将需要氧合技术和增强型心臟手术设备的应用。随着全球对改善心臟护理的持续关注，氧合器市场预计将大幅成长。随着心臟病发病率的上升以及医疗技术的进步，需要氧合过程的手术对创新解决方案的需求不断增长，从而推动该市场的整体成长。

老年人口不断增加

65岁及以上人口数将增加一倍以上，从2021年的7.61亿增至2050年的16亿，而80岁及以上人口的增长速度可能更快。联合国的数据显示，人口结构变化表明，心血管疾病和呼吸系统疾病等与年龄相关的疾病正在迅速增长，其中大多数疾病都需要先进的氧合解决方案。因此，医疗保健需求的成长正推动氧合器进入重症监护领域，并扩大氧合器市场。随着人口老化，医疗保健系统注定将面临许多挑战。因此，随着老年人得到更好的治疗和护理，对氧合器的需求可能很快就会增加。

战略创新与整合系统

市场参与者正在进行策略性创新，以满足日益增长的消费者需求，尤其是透过改进整合氧合器的系统。该系列的一项重要产品是LivaNova Essenz灌注系统，该系统于2024年4月上市。该系统专为成人和儿童开胸心臟外科手术患者设计，结合多种主要元件，以提高手术效率和安全性。该系统整合了先进的薄膜式氧合器和其他关键元件，这些元件已成为业界向综合心臟护理解决方案转型的标誌。在改善手术效果的同时，创新也透过在医疗器材的复杂性和功能性方面树立新的标桿，为全球氧合器市场的成长做出了重大贡献。

目录

第一章：前言

第二章：范围与方法

  • 研究目标
  • 利害关係人
  • 资料来源
    • 主要来源
    • 次要来源
  • 市场评估
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第三章：执行摘要

第四章：简介

  • 概述
  • 主要行业趋势

第五章：全球氧合器市场

  • 市场概览
  • 市场表现
  • COVID-19的影响
  • 市场预测

第六章：市场细分：依类型

  • 膜氧合器
  • 气泡氧合器

第七章：市场区隔：依年龄段

  • 新生儿
  • 儿科
  • 成年人

第 8 章：市场区隔：按应用

  • 呼吸系统
  • 心臟
  • 体外循环心肺
  • 復苏（体外循环復苏）

第九章：市场细分：依地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲
    • 市场区隔：依国家

第十章：SWOT分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 11 章：价值链分析

第 12 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第十三章：价格分析

第 14 章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Braile Biomedica
    • Chalice Medical Ltd
    • Eurosets Srl
    • Getinge AB
    • Livanova Plc
    • Medtronic plc
    • MicroPort
    • Nipro Corporation
    • Senko Medical Instrument Mfg. Co. Ltd.
    • Terumo Medical Corporation (Terumo Corporation)
    • Xenios AG (Fresenius Medical Care AG & Co. KGaA)
Product Code: SR112025A6448

The global oxygenator market size was valued at USD 271.9 Million in 2024. Looking forward, IMARC Group estimates the market to reach USD 419.52 Million by 2033, exhibiting a CAGR of 4.94% from 2025-2033. North America currently dominates the market, holding a market share of over 45.3% in 2024. The market is driven by the high prevalence of cardiovascular and respiratory diseases, increasing surgical procedures, and strong healthcare infrastructure advancements in the region.

The global oxygenator market is driven by the growing prevalence of cardiovascular and respiratory diseases worldwide. According to the World Health Organization (WHO), the mortality risk for cardiovascular disease (CVDs), cancer, diabetes, or chronic respiratory disease between the ages of 30 and 70 is 18%. This has increased the demand for oxygenators in critical care and surgeries, aiding the market growth. Moreover, ongoing advancements in medical technology have improved oxygenator efficiency and safety, boosting adoption rates, and fueling the market demand. Besides this, the rising geriatric populations are contributing to the market expansion, as chronic health conditions require oxygenation support. Also, the increasing number of surgical procedures, especially open-heart surgeries is impelling the market growth. Furthermore, the expanding healthcare infrastructure in emerging economies enhances access to advanced medical devices, catalyzing the market growth.

The United States oxygenator market holds a market share of 83.20%. The demand in the region is driven by a high prevalence of cardiovascular and pulmonary diseases. In line with this, the aging population contributes significantly, as elderly individuals are more susceptible to chronic conditions requiring oxygenation support. Also, the country's well-developed healthcare system ensures widespread access to cutting-edge technologies, fostering the market growth. Concurrently, the increased numbers of cardiac surgeries and extracorporeal membrane oxygenation (ECMO) procedures, are providing an impetus to the market. Apart from this, continuous technological advancements in oxygenators enhance efficiency and safety, boosting adoption and propelling the market forward.

Oxygenators Market Trends:

Growing Prevalence of Heart Disease

Heart disease cases represent the main cause of the increased demand for oxygenators throughout the globe. Research published by the British Heart Foundation in January 2024 has found that some 640 million people suffering from heart and circulatory diseases reside in Asia alone. With a steadily increased number of patients, patients will demand the application of oxygenation technology and enhanced cardiac surgery devices. The oxygenators market is expected to grow massively with continued global attention being focused on improving cardiac care. With the increase in the incidence of heart diseasebi, along with advances in medical technologies, there's a demand for innovative solutions in surgeries that require the oxygenation process, resulting in overall growth in this market.

Rising Geriatric Population

The number of people aged 65 and older will more than double, from 761 million in 2021 to 1.6 billion by 2050, and the population aged 80 and above is likely to grow even faster. According to the United Nations, demographic shifts indicate that age-related conditions such as cardiovascular and respiratory disorders are increasing at a very high rate, most of which demand advanced oxygenation solutions. Hence, the increased demand for healthcare is pushing oxygenators into critical care areas and increasing the markets for oxygenators. With the aging population, healthcare systems are destined to face several challenges. Thus, oxygenators are likely to see a rise in demand shortly as the elderly are treated and cared for better.

Strategic Innovations and Integrated Systems

Market players are making strategic innovations to keep up with the growing demand from consumers, especially through improving systems that integrate oxygenators. One of the key releases in this line is the LivaNova Essenz Perfusion System which hit the market in April 2024. It is designed for both adults and pediatric open-heart surgery patients, combining several main elements to make surgical efficiency and safety more achievable. The system integrates advanced membrane oxygenators and other critical elements, which have become a hallmark of the industry's shift toward comprehensive cardiac care solutions. While improving procedural outcomes, innovations are also significantly contributing to the growth of the global oxygenators market by establishing new benchmarks in medical device sophistication and functionality.

Oxygenators Industry Segmentation:

Analysis by Type:

  • Membrane Oxygenator
  • Bubble Oxygenator

Membrane oxygenators dominate the oxygenator segment because of their high performance and versatility in various clinical settings and operations. The growth of this segment is further attributed to the growing incidence of cardiovascular and respiratory diseases which necessitate extracorporeal oxygenation support. Additionally, the development of new membranes has enhanced the efficiency of the gas exchange and increased the durability and biocompatibility of the membrane, which is increasing the uptake of the equipment. High incidences of cardiac and pulmonary procedures such as open heart procedures are major drivers of increased demand. Another factor is the increasing population of geriatric patients who are more susceptible to chronic diseases and thus require oxygenators. Moreover, the growing use of extracorporeal membrane oxygenation or ECMO therapy in the critical care segment contributes to the segment's visibility. Furthermore, pressures towards patient safety and clinical outcomes have made people prefer membrane oxygenators to bubble oxygenators, to ensure they gain more market standards.

Analysis by Age Group:

  • Neonates
  • Pediatric
  • Adults

The neonate segment in the oxygenator market is driven by the increasing prevalence of congenital heart defects and respiratory complications in newborns. Specialized oxygenators designed for delicate physiology ensure precise gas exchange and temperature control, essential for neonatal care. Growing neonatal intensive care units (NICUs) and advancements in pediatric cardiac surgery further bolster demand for neonatal oxygenators, driving the market forward.

The pediatric segment is growing due to increasing incidences of congenital heart diseases and respiratory diseases among children. Pediatric oxygenators are designed to suit the sizes and metabolic requirements of children. Moreover, ongoing technological enhancements in pediatric surgical procedures and ECMO therapies along with rising awareness of early management of chronic ailments are providing an impetus to the market.

The adult segment dominates due to the high incidence of cardiovascular diseases, respiratory failures, and surgeries requiring oxygenation support. Aging populations and lifestyle-related conditions like obesity and smoking increase demand. Advanced oxygenator technologies enhance safety and efficiency in adult surgeries while expanding critical care and ECMO usage for severe respiratory conditions further fueling the market growth.

Analysis by Application:

  • Respiratory
  • Cardiac
  • Extracorporeal Cardiopulmonary
  • Resuscitation (ECPR)

Respiratory leads the market with a share of 59.3%. This segment dominates the oxygenator market, driven by the increasing prevalence of respiratory diseases such as chronic obstructive pulmonary disease (COPD), acute respiratory distress syndrome (ARDS), and pneumonia. In addition, the rising pollution levels and smoking rates exacerbate respiratory health issues, boosting the demand for oxygenators. The segment also benefits from the growing adoption of ECMO therapy for severe respiratory failure. Moreover, continuous advancements in oxygenator technology, including improved biocompatibility and gas exchange efficiency, enhance their suitability for long-term respiratory support. Concurrently, the aging population is more prone to chronic respiratory conditions, which is another critical growth factor. Apart from this, the expanding healthcare infrastructure and critical care capabilities in emerging markets are boosting the adoption of oxygenators in respiratory care and increasing awareness of advanced respiratory therapies.

Regional Analysis:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

North America dominates the oxygenator market with a share of 45.3%. The demand in this segment is driven by advanced healthcare infrastructure and the high prevalence of cardiovascular and respiratory diseases. The aging population of the region is significantly contributing to the market growth, as elderly individuals are more prone to conditions requiring oxygenation support. Moreover, the increasing adoption of ECMO therapy in critical care settings further fuels demand. The region also benefits from robust R&D activities, leading to continuous advancements in oxygenator technologies that enhance efficiency, safety, and biocompatibility. The high volume of surgical procedures, particularly cardiac and pulmonary surgeries, boosts the utilization of oxygenators. Besides this, favorable reimbursement policies and increasing healthcare expenditure support widespread adoption, thereby impelling the market growth.

Key Regional Takeaways:

United States Oxygenators Market Analysis

The rising prevalence of chronic obstructive pulmonary disease, which is the third leading cause of death in the U.S. aside from cancer and heart conditions, is one of the biggest factors in oxygenators uptake. The American Lung Association says that 11 million people are diagnosed with COPD in the country yearly, thus the more urgent need for respiratory-based health care. This trend is expected to increase the demand for membrane oxygenators, which are widely used in ECMO devices to provide life support to patients with severe cardiopulmonary diseases. Membrane oxygenators are advanced over the traditional bubble oxygenators. They offer features such as better platelet functioning, higher platelet count, and reduced hemolysis during perfusion. These features enhance patient outcomes while making them more attractive in critical care. Demand for advanced respiratory support devices is on the rise which will expand the use of membrane oxygenators and augment the growth of the market for oxygenators in the U.S.

Europe Oxygenators Market Analysis

The significant burden of circulatory system diseases on healthcare systems and government budgets will drive the Europe oxygenators market. According to an industrial report, there were 1.71 million deaths in the EU because of diseases in the circulatory system in 2021, representing 32.4% of all deaths. That trend is expected to be maintained, thus boosting the demand for oxygenators to treat patients with disorders of the circulatory system. Such higher prevalence in the region's areas of coronary artery disease, heart failure, and pulmonary embolism will contribute more to market growth. It is the increasing adoption of minimally invasive surgical procedures and the incidence of respiratory disease that adds to demand and growth. European healthcare is shifting toward the oxygenation of advanced therapy methods to further improve the chances of improved patient outcomes through reduced cost of healthcare and other preventive measures. As a result, the Europe oxygenators market is expected to see remarkable growth, with the prominent players investing in research and development to innovate and further improve oxygenator technology. This trend is likely to continue as the demand for effective and efficient oxygenation therapies increases.

Asia Pacific Oxygenators Market Analysis

The significant burden of circulatory system diseases on healthcare systems and government budgets will drive the Asia Pacific oxygenators market. India forms a fifth of the total deaths due to coronary heart disease worldwide, and deaths due to CHD are up by 100% since 1990, as per industrial reports. It is estimated to further increase by 50% by 2030. In addition, the contribution of the region in curbing major diseases, such as that of South Korea donating USD 4 million to Indonesia in 2021, further fuels the market for oxygenators. The increasing adoption of minimally invasive surgical procedures and the rising incidence of respiratory diseases will also drive demand. As the Asian healthcare sector shifts towards advanced oxygenation therapies to improve patient outcomes and reduce healthcare costs, the demand for effective and efficient oxygenation therapies is expected to increase. The Asia Pacific oxygenators market is expected to witness remarkable growth as the key players in the market invest in research and development for innovation and improvement in oxygenator technology.

Latin America Oxygenators Market Analysis

The burden of chronic respiratory diseases in Latin America will drive the Latin America oxygenators market. Chronic obstructive pulmonary disease (COPD) and tuberculosis are leading causes of morbidity and mortality in Brazil. In addition, smoking is a key factor in the growth of the respiratory devices market; 9.1% of the population aged 15+ years smokes daily, according to OECD statistics for 2021. Significant tobacco use will increase the risk of developing respiratory diseases such as asthma and COPD. Growth in the increasing rates of tuberculosis in Brazil according to the WHO Global Tuberculosis Report, dated 2022, further fuels the market. The incidence of tuberculosis in Brazil stood at 48 per 100,000 people in 2021. In turn, a high prevalence of smoking and tuberculosis is expected to propel the Latin America oxygenators market across the forecast period, wherein the demand for effective and efficient oxygenation therapies rises to enhance patient outcomes as well as reduce healthcare costs.

Middle East and Africa Oxygenators Market Analysis

The Middle East and Africa oxygenators market will be propelled by the high incidence burden of asthma in this region. For instance, asthma has a severe burden in countries like Uganda with mortality 90 times greater than that found in the United Kingdom. A study by the Journal of the Pan African Thoracic Society (JPATS) showed that only 33% of asthma patients in Uganda had the disease in control, pointing out the lack of awareness about monitoring and the severity of the disease. The adoption of cost-effective solutions such as pulse oximeters for respiratory monitoring will spur the growth of the market. As the healthcare sector in the region shifts toward advancing technologies to improve patient outcomes and reduce healthcare costs, the demand for effective and efficient oxygenation therapies is expected to increase. Additionally, the rising prevalence of respiratory diseases and increased awareness of asthma management will also drive demand for oxygenators in the Middle East and Africa.

Competitive Landscape:

The competitive landscape of the oxygenator market is characterized by intense innovation and strategic activities among key players. Companies are heavily investing in research and development (R&D) to enhance oxygenator efficiency, biocompatibility, and safety. Mergers, acquisitions, and collaborations are common strategies to expand product portfolios and market presence. Major trends include the integration of advanced materials and the development of portable and lightweight oxygenators for improved usability. Moreover, regulatory approvals for novel products further drive competition. Also, the increasing focus on ECMO systems and personalized solutions tailored to patient needs is shaping market dynamics. Additionally, partnerships with healthcare providers and institutions strengthen distribution networks, enhancing players' competitive edge.

The report provides a comprehensive analysis of the competitive landscape in the oxygenator market with detailed profiles of all major companies, including:

  • Braile Biomedica
  • Chalice Medical Ltd
  • Eurosets S.r.l.
  • Getinge AB
  • Livanova Plc
  • Medtronic plc
  • MicroPort
  • Nipro Corporation
  • Senko Medical Instrument Mfg. Co. Ltd.
  • Terumo Medical Corporation (Terumo Corporation)
  • Xenios AG (Fresenius Medical Care AG & Co. KGaA)

Key Questions Answered in This Report

  • 1.What is oxygenator?
  • 2.How big is the global oxygenator market?
  • 3.What is the expected growth rate of the global oxygenator market during 2025-2033?
  • 4.What are the key factors driving the global oxygenator market?
  • 5.What is the leading segment of the global oxygenator market based on type?
  • 6.What is the leading segment of the global oxygenator market based on application?
  • 7.What are the key regions in the global oxygenator market?
  • 8.Who are the key players/companies in the global oxygenator market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Oxygenators Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Type

  • 6.1 Membrane Oxygenator
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Bubble Oxygenator
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Age Group

  • 7.1 Neonates
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Pediatric
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Adults
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by Application

  • 8.1 Respiratory
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Cardiac
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Extracorporeal Cardiopulmonary
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Resuscitation (ECPR)
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Braile Biomedica
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
    • 14.3.2 Chalice Medical Ltd
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
    • 14.3.3 Eurosets S.r.l.
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
    • 14.3.4 Getinge AB
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 Livanova Plc
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
    • 14.3.6 Medtronic plc
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 MicroPort
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
    • 14.3.8 Nipro Corporation
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 Senko Medical Instrument Mfg. Co. Ltd.
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
    • 14.3.10 Terumo Medical Corporation (Terumo Corporation)
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
    • 14.3.11 Xenios AG (Fresenius Medical Care AG & Co. KGaA)
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio

List of Figures

  • Figure 1: Global: Oxygenators Market: Major Drivers and Challenges
  • Figure 2: Global: Oxygenators Market: Sales Value (in Million USD), 2019-2024
  • Figure 3: Global: Oxygenators Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 4: Global: Oxygenators Market: Breakup by Type (in %), 2024
  • Figure 5: Global: Oxygenators Market: Breakup by Age Group (in %), 2024
  • Figure 6: Global: Oxygenators Market: Breakup by Application (in %), 2024
  • Figure 7: Global: Oxygenators Market: Breakup by Region (in %), 2024
  • Figure 8: Global: Oxygenators (Membrane Oxygenator) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 9: Global: Oxygenators (Membrane Oxygenator) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 10: Global: Oxygenators (Bubble Oxygenator) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 11: Global: Oxygenators (Bubble Oxygenator) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 12: Global: Oxygenators (Neonates) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 13: Global: Oxygenators (Neonates) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 14: Global: Oxygenators (Pediatric) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 15: Global: Oxygenators (Pediatric) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 16: Global: Oxygenators (Adults) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 17: Global: Oxygenators (Adults) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 18: Global: Oxygenators (Respiratory) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 19: Global: Oxygenators (Respiratory) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 20: Global: Oxygenators (Cardiac) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 21: Global: Oxygenators (Cardiac) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 22: Global: Oxygenators (Extracorporeal Cardiopulmonary) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 23: Global: Oxygenators (Extracorporeal Cardiopulmonary) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 24: Global: Oxygenators (Resuscitation-ECPR) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 25: Global: Oxygenators (Resuscitation-ECPR) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 26: North America: Oxygenators Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 27: North America: Oxygenators Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 28: United States: Oxygenators Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 29: United States: Oxygenators Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 30: Canada: Oxygenators Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 31: Canada: Oxygenators Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 32: Asia-Pacific: Oxygenators Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 33: Asia-Pacific: Oxygenators Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 34: China: Oxygenators Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 35: China: Oxygenators Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 36: Japan: Oxygenators Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 37: Japan: Oxygenators Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 38: India: Oxygenators Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 39: India: Oxygenators Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 40: South Korea: Oxygenators Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 41: South Korea: Oxygenators Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 42: Australia: Oxygenators Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 43: Australia: Oxygenators Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 44: Indonesia: Oxygenators Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 45: Indonesia: Oxygenators Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 46: Others: Oxygenators Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 47: Others: Oxygenators Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 48: Europe: Oxygenators Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 49: Europe: Oxygenators Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 50: Germany: Oxygenators Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 51: Germany: Oxygenators Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 52: France: Oxygenators Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 53: France: Oxygenators Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 54: United Kingdom: Oxygenators Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 55: United Kingdom: Oxygenators Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 56: Italy: Oxygenators Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 57: Italy: Oxygenators Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 58: Spain: Oxygenators Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 59: Spain: Oxygenators Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 60: Russia: Oxygenators Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 61: Russia: Oxygenators Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 62: Others: Oxygenators Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 63: Others: Oxygenators Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 64: Latin America: Oxygenators Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 65: Latin America: Oxygenators Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 66: Brazil: Oxygenators Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 67: Brazil: Oxygenators Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 68: Mexico: Oxygenators Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 69: Mexico: Oxygenators Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 70: Others: Oxygenators Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 71: Others: Oxygenators Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 72: Middle East and Africa: Oxygenators Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 73: Middle East and Africa: Oxygenators Market: Breakup by Country (in %), 2024
  • Figure 74: Middle East and Africa: Oxygenators Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 75: Global: Oxygenators Industry: SWOT Analysis
  • Figure 76: Global: Oxygenators Industry: Value Chain Analysis
  • Figure 77: Global: Oxygenators Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Oxygenators Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Oxygenators Market Forecast: Breakup by Type (in Million USD), 2025-2033
  • Table 3: Global: Oxygenators Market Forecast: Breakup by Age Group (in Million USD), 2025-2033
  • Table 4: Global: Oxygenators Market Forecast: Breakup by Application (in Million USD), 2025-2033
  • Table 5: Global: Oxygenators Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 6: Global: Oxygenators Market: Competitive Structure
  • Table 7: Global: Oxygenators Market: Key Players